Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Perhaps my concerns are wrong. It is always good to do portfolio management, don't put all the money into 1 bucket, perhaps the most is 20%, to control the risks, coz sometime we get the wrong info to make judgement. This is my last comment. All the best and stay safe.
Hi, guys. Look at company balance sheet, it only has 10m which mostly derived from private placement 12m last quarter. Does this 10m sufficient for company to manufacture vaccine? If provide service still sounds ok. Look at operating cash flow, it is negative.
To produce vaccine, not easy. Need a lot of money and talents, does the company fulfill all these criteria? Why other people want to cooperate with Ucrest instead of other medical company with strong fundamental? Company cash balance only 10m and has no relevant resources. If goreng, yes. If investment, think twice and do more research.
hi, Darren. 1. Revenu derived from Russia is RM6.772m, not 6,772 million. 2. Go and check on company history, and check for their retained earning in balance sheet, up to last year, they still have no retained earning but accumulated losses. A company listed for so many years, still making losses up to last year. For this year profit, I highly doubt on it as receivable increased a lot. Net operating cash flow show negative. 3. Mou, even agreement can be cancel anytime.
